Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00218699 · ClinicalTrials.gov registry record · NA

Pre-HIV Test Counseling Intervention to Reduce HIV Infection Risk Behavior in Men Who Are Not HIV Infected

A NA study of HIV Infections, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT00218699: Completed NA study of HIV Infections, sponsored by University of California, San Francisco.

NCT00218699 is a NA study of HIV Infections that has completed, run by University of California, San Francisco. The registered enrollment target is 300 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00218699, a NA study of HIV Infections, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the effectiveness of a single specialized pre-test counseling session in reducing HIV infection risk behavior in men who are not HIV infected.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive-Behavioral Intervention

Study Locations (1)

California

  • UCSF AIDS Health Project - San Francisco

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2002-08
Est. Completion 2005-09
Phase NA

What the finished NCT00218699 record still lists

NCT00218699 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (33% lower).

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Cognitive-Behavioral Intervention is the first listed.

NCT00218699 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00218699 about?

NCT00218699 is a clinical study titled "Pre-HIV Test Counseling Intervention to Reduce HIV Infection Risk Behavior in Men Who Are Not HIV Infected". This study will evaluate the effectiveness of a single specialized pre-test counseling session in reducing HIV infection risk behavior in men who are not HIV infected.

What is the current status of trial NCT00218699?

This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2002-08. Estimated completion is 2005-09.

What conditions does trial NCT00218699 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT00218699?

The interventions under investigation include: Cognitive-Behavioral Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00218699?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00218699 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00218699's enrollment target sits among peer trials

300 115th of 542 higher than 417 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00218699, the US trial registry maintained by the National Library of Medicine. NCT00218699 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.